Current Immunotherapies for Glioblastoma Multiforme.
Huang B, Li X, Li Y, Zhang J, Zong Z, Zhang H.
Front Immunol. 2021 Mar 9;11:603911. doi: 10.3389/fimmu.2020.603911. eCollection 2020.
PMID:33767690
Turning cold tumors hot: from molecular mechanisms to clinical applications.
Zhang J, Huang D, Saw PE, Song E.
Trends Immunol. 2022 Jul;43(7):523-545. doi: 10.1016/j.it.2022.04.010. Epub 2022 May 25.
PMID:35624021
Phage display screening of therapeutic peptide for cancer targeting and therapy.
Saw PE, Song EW.
Protein Cell. 2019 Nov;10(11):787-807. doi: 10.1007/s13238-019-0639-7. Epub 2019 May 28.
PMID:31140150
Contradictory roles of lipid metabolism in immune response within the tumor microenvironment.
Yu W, Lei Q, Yang L, Qin G, Liu S, Wang D, Ping Y, Zhang Y.
J Hematol Oncol. 2021 Nov 6;14(1):187. doi: 10.1186/s13045-021-01200-4.
PMID:34742349
The evolving landscape of tissue-agnostic therapies in precision oncology.
Subbiah V, Gouda MA, Ryll B, Burris HA 3rd, Kurzrock R.
CA Cancer J Clin. 2024 Sep-Oct;74(5):433-452. doi: 10.3322/caac.21844. Epub 2024 May 30.
PMID:38814103
(Nano)platforms in breast cancer therapy: Drug/gene delivery, advanced nanocarriers and immunotherapy.
Ashrafizadeh M, Zarrabi A, Bigham A, Taheriazam A, Saghari Y, Mirzaei S, Hashemi M, Hushmandi K, Karimi-Maleh H, Nazarzadeh Zare E, Sharifi E, Ertas YN, Rabiee N, Sethi G, Shen M.
Med Res Rev. 2023 Nov;43(6):2115-2176. doi: 10.1002/med.21971. Epub 2023 May 11.
PMID:37165896
Landscape of somatic alterations in large-scale solid tumors from an Asian population.
Wu L, Yao H, Chen H, Wang A, Guo K, Gou W, Yu Y, Li X, Yao M, Yuan S, Pang F, Hu J, Chen L, Liu W, Yao J, Zhang S, Dong X, Wang W, Hu J, Ling Q, Ding S, Wei Y, Li Q, Cao W, Wang S, Di Y, Feng F, Zhao G, Zhang J, Huang L, Xu J, Yan W, Tong Z, Jiang D, Ji T, Li Q, Xu L, He H, Shang L, Liu J, Wang K, Wu D, Shen J, Liu Y, Zhang T, Liang C, Wang Y, Shang Y, Guo J, Liang G, Xu S, Liu J, Wang K, Wang M.